A real world study analysing use of ocrelizumab in older progressive multiple sclerosis patients
Latest Information Update: 25 Mar 2021
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Mar 2021 New trial record
- 27 Feb 2021 Results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021